Ventolin, 100 μg/dose inhalation, inhalation aerosol, suspension
Salbutamol
Ventolin inhalation aerosol, suspension, contains a medicine called salbutamol. It belongs to a group of
quick-acting bronchodilators.
Bronchodilators:
Before starting to use Ventolin inhalation aerosol, the patient should consult their doctor if they:
➔ If the patient is taking any of these medicines, the doctor will recommend monitoring potassium levels in the blood.
➔ The patient should consult their doctor if any of these circumstances apply to them.
The patient should consult their doctor if the duration of action of the medicine is less than 3 hours.
The patient should tell their doctor about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take, including those available without a prescription.
Some medicines may affect the action of Ventolin inhalation aerosol or increase the risk of side effects. These include:
➔ The doctor will decide whether the patient can use Ventolin inhalation aerosol with these medicines.
Ventolin inhalation aerosol is not usually recommended for use during pregnancy.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before using this medicine. The doctor will assess whether the patient can take Ventolin during this period.
No effect on the ability to drive and use machines has been observed.
Ventolin inhalation aerosol should always be used as directed by the doctor. If in doubt, the patient should consult their doctor.
Ventolin inhalation aerosol is for inhalation use only.
The dose or frequency of use should only be increased under medical supervision.
Patients who have difficulty coordinating inhalation and actuation of the inhaler may use Ventolin inhalation aerosol with a spacer.
Children under 5 years of age may use Ventolin inhalation aerosol with a Babyhaler spacer.
Ventolin inhalation aerosol should be used as needed, not regularly.
If the patient's asthma is active (e.g., they experience frequent symptoms or exacerbations, such as shortness of breath that interferes with speaking, eating, or sleeping, coughing, wheezing, chest tightness, or reduced physical fitness), they should immediately consult their doctor, who may initiate treatment or increase the dose of a medicine that helps control asthma symptoms, such as an inhaled corticosteroid.
If the patient thinks the medicine is not working as well as usual, they should consult their doctor as soon as possible (e.g., if they need higher doses to relieve breathing problems or if asthma symptoms do not improve for at least 3 hours after using the inhaler), as their asthma may be worsening and another medicine may be needed.
If the patient uses Ventolin inhalation aerosol more frequently than twice a week to relieve asthma symptoms, excluding preventive use before physical exertion, it means that their asthma is not well controlled and may increase the risk of severe asthma attacks (asthma exacerbations), which can cause serious complications and be life-threatening. The patient should consult their doctor as soon as possible to verify their asthma treatment. If the patient uses a medicine with anti-inflammatory effects in the lungs, e.g., an inhaled corticosteroid, every day, it is essential to continue using it regularly, even if they feel better.
The patient should tell their doctor if the medicine does not work as it has before, as this may be due to worsening asthma control and a change in medicine may be necessary.
The maximum daily dose is 800 micrograms (2 inhalations no more than 4 times in 24 hours).
The maximum daily dose is 800 micrograms (2 inhalations no more than 4 times in 24 hours).
The doctor, nurse, or pharmacist should instruct the patient on how to use the inhaler properly.
The medicine is in a pressurized container with a plastic actuator and mouthpiece.
Before first use, check that the inhaler works. Remove the cap from the mouthpiece by gently pressing the sides of the cap with your thumb and index finger.
Figure 1
To ensure the inhaler works, shake it vigorously, point the mouthpiece away from you, and release a dose of the medicine into the air.
If the inhaler has not been used for a week or longer, remove the mouthpiece cap, shake the inhaler vigorously, and release two doses of the medicine into the air.
It is essential to start slow breathing, as slow as possible, before using the inhaler.
Figure 2
It is essential not to rush the actions described in points 4-7.
Figure 3
Figure 4
Figure 5
Figure 6
To prevent the inhaler from clogging, clean it at least once a week. To clean the inhaler:
Do not immerse the metal canister in water.
If a higher dose of Ventolin than recommended is used, the patient should contact their doctor or pharmacist as soon as possible for advice. The patient should have the carton of the medicine with them to show the doctor.
The following symptoms may occur:
If a dose of Ventolin inhalation aerosol is missed, the patient should take it as soon as possible and then continue taking the medicine as directed by the doctor.
The patient should not take a double dose of the medicine to make up for a missed dose.
If the patient has any further doubts about using the medicine, they should consult their doctor or pharmacist.
Like all medicines, Ventolin inhalation aerosol can cause side effects, although not everybody gets them.
The following side effects have been observed in patients taking Ventolin inhalation aerosol.
Symptoms to watch out for
Allergic reactions:These occur very rarely (i.e., less frequently than in 1 in 10,000 patients taking the medicine). Symptoms include:
➔ The patient should contact their doctor immediately if they experience any of these symptoms. Stop using Ventolin inhalation aerosol.
The patient should contact their doctor immediately if they experience:
Common side effects(i.e., occurring in less than 1 in 10 patients, but more than 1 in 100 patients taking the medicine):
Uncommon side effects(i.e., occurring in less than 1 in 100 patients, but more than 1 in 1,000 patients taking the medicine):
Rare side effects(i.e., occurring in less than 1 in 1,000 patients, but more than 1 in 10,000 patients taking the medicine):
Very rare side effects(i.e., occurring in less than 1 in 10,000 patients taking the medicine):
Side effects of unknown frequency
➔ If any side effect worsens or if any side effects not listed in the leaflet occur, the patient should tell their doctor or pharmacist.
If side effects occur, including any side effects not listed in the leaflet, the patient should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder or its representative.
Reporting side effects will help gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature not exceeding 30°C.
Do not freeze.
The container contains a pressurized suspension. Do not expose to temperatures above 50°C, protect from direct sunlight. Do not pierce, damage, burn, or throw away the container, even if it seems empty.
As with most inhaled medicines in pressurized containers, the effectiveness of the medicinal product may be reduced if the inhaler is cold.
After inhalation, always replace the cap on the mouthpiece. Do not force the cap on.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month stated. It is stated on the packaging after the abbreviation "EXP".
The batch number of the medicine is stated on the packaging after the abbreviation "Lot".
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines they no longer use. This will help protect the environment.
This medicine contains fluorinated greenhouse gases.
Each inhaler contains 18 g of HFC-134a (also known as 1,1,1,2-tetrafluoroethane or HFA 134a), which corresponds to 0.0257 tons of CO2 equivalent (GWP = 1430).
An aluminum canister containing 200 doses, closed with a metering valve, equipped with a plastic actuator, in a cardboard box.
Glaxo Wellcome Production
Zone Industrielle No. 2
23, rue Lavoisier
27000 Evreux
France
Glaxo Wellcome S.A.
Avenida de Extremadura 3
09400 Aranda de Duero
Burgos,
Spain
To obtain more detailed information, the patient should contact the representative of the marketing authorization holder:
GSK Services Sp. z o.o.
ul. Rzymowskiego 53
02-697 Warsaw
tel. (22) 576-90-00
GlaxoSmithKline Trading Services Limited
12 Riverwalk
Citywest Business Campus
Dublin 24
D24 YK11
Ireland
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.